10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BZYR (Burzynski Research) Stock Analysis
Buy, Hold or Sell?

Let's analyze Burzynski Research together

I guess you are interested in Burzynski Research. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Burzynski Research’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Burzynski Research’s Price Targets

I'm going to help you getting a better view of Burzynski Research. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Burzynski Research

I send you an email if I find something interesting about Burzynski Research.

1. Quick Overview

1.1. Quick analysis of Burzynski Research (30 sec.)










1.2. What can you expect buying and holding a share of Burzynski Research? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-0.1%

For what price can you sell your share?

Current Price per Share
$0.06
Expected price per share
$0.031 - $0.055
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Burzynski Research (5 min.)




Live pricePrice per Share (EOD)
$0.06
Intrinsic Value Per Share
$-0.02 - $-0.02
Total Value Per Share
$-0.02 - $-0.02

2.2. Growth of Burzynski Research (5 min.)




Is Burzynski Research growing?

Current yearPrevious yearGrowGrow %
How rich?-$41.6k-$36.6k-$24.1k-39.7%

How much money is Burzynski Research making?

Current yearPrevious yearGrowGrow %
Making money-$349.8k-$324.1k-$25.6k-7.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Burzynski Research (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#760 / 884

Most Revenue
#729 / 884

Most Profit
#194 / 884

Most Efficient
#313 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Burzynski Research?

Welcome investor! Burzynski Research's management wants to use your money to grow the business. In return you get a share of Burzynski Research.

First you should know what it really means to hold a share of Burzynski Research. And how you can make/lose money.

Speculation

The Price per Share of Burzynski Research is $0.055. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Burzynski Research.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Burzynski Research, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Burzynski Research.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-4.0%0.00-4.8%0.00-4.5%0.00-4.3%0.00-4.1%0.00-4.9%
Usd Book Value Change Per Share0.00-0.3%0.000.0%0.00-0.1%0.000.0%0.000.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.3%0.000.0%0.00-0.1%0.000.0%0.000.1%0.000.0%
Usd Price Per Share0.06-0.04-0.05-0.04-0.04-0.04-
Price to Earnings Ratio-6.51--3.86--5.44--4.10--4.11--4.09-
Price-to-Total Gains Ratio-375.36-16.86--75.22-6.26--32.55-153.13-
Price to Book Ratio-183.11--124.98--560.11--256.15-14.98--29.63-
Price-to-Total Gains Ratio-375.36-16.86--75.22-6.26--32.55-153.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.055
Number of shares18181
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (18181 shares)-0.190.93
Gains per Year (18181 shares)-0.753.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1-1104-6
20-2-1207-2
30-2-130112
40-3-140156
50-4-1501910
60-5-1602214
70-5-1702618
80-6-1803022
90-7-1903426
100-8-2003730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.05.00.00.0%0.012.00.00.0%0.021.00.00.0%0.040.00.00.0%0.0100.00.00.0%
Book Value Change Per Share3.02.00.060.0%6.06.00.050.0%12.09.00.057.1%21.019.00.052.5%46.052.02.046.0%
Dividend per Share0.00.05.00.0%0.00.012.00.0%0.00.021.00.0%0.00.040.00.0%0.00.0100.00.0%
Total Gains per Share3.02.00.060.0%6.06.00.050.0%12.09.00.057.1%21.019.00.052.5%46.052.02.046.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Burzynski Research compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.000-93%0.000-65%0.000-82%0.000-401%0.000-940%
Book Value Per Share--0.0000.000+46%0.000-12%0.000+1%0.000+56%-0.001+129%
Current Ratio--0.0200.032-39%0.109-82%0.076-74%0.353-94%0.229-91%
Debt To Asset Ratio--50.15855.485-10%41.012+22%36.807+36%33.594+49%45.140+11%
Debt To Equity Ratio----0%-0%-0%0.149-100%0.078-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--7581525.7525196610.760+46%6544176.096+16%4916181.217+54%4535004.335+67%6059812.245+25%
Eps---0.002-0.003+19%-0.002+11%-0.002+6%-0.002+0%-0.003+22%
Free Cash Flow Per Share--0.000-0.001+125%-0.001+175%-0.001+107%-0.001+102%-0.001+102%
Free Cash Flow To Equity Per Share--0.0000.000+106%0.000+103%0.000+190%0.000+685%0.000+115%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.020----------
Intrinsic Value_10Y_min---0.023----------
Intrinsic Value_1Y_max---0.003----------
Intrinsic Value_1Y_min---0.003----------
Intrinsic Value_3Y_max---0.008----------
Intrinsic Value_3Y_min---0.008----------
Intrinsic Value_5Y_max---0.012----------
Intrinsic Value_5Y_min---0.013----------
Market Cap7229640.000-5%7624009.7525257937.760+45%6581185.430+16%4958892.550+54%4601947.430+66%5697961.426+34%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio-173.636+5%-183.107-124.976-32%-560.113+206%-256.151+40%14.983-1322%-29.630-84%
Pe Ratio-6.173+5%-6.510-3.861-41%-5.443-16%-4.095-37%-4.110-37%-4.093-37%
Price Per Share0.055-5%0.0580.040+45%0.050+16%0.038+54%0.035+66%0.043+34%
Price To Free Cash Flow Ratio-38.634+5%-40.741-17.529-57%-16.776-59%-16.191-60%-14.308-65%-19.212-53%
Price To Total Gains Ratio-355.948+5%-375.36416.857-2327%-75.219-80%6.256-6100%-32.550-91%153.127-345%
Quick Ratio---0.018-100%0.083-100%0.054-100%0.278-100%0.150-100%
Return On Assets---345.688-319.625-8%-302.224-13%-244.122-29%-178.241-48%-206.453-40%
Return On Equity----0%-0%-0%-9.1040%-4.7800%
Total Gains Per Share--0.0000.000-93%0.000-65%0.000-82%0.000-401%0.000-940%
Usd Book Value---41637.000-60717.600+46%-36609.333-12%-42174.083+1%-64890.810+56%-95250.275+129%
Usd Book Value Change Per Share--0.0000.000-93%0.000-65%0.000-82%0.000-401%0.000-940%
Usd Book Value Per Share--0.0000.000+46%0.000-12%0.000+1%0.000+56%-0.001+129%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--7581525.7525196610.760+46%6544176.096+16%4916181.217+54%4535004.335+67%6059812.245+25%
Usd Eps---0.002-0.003+19%-0.002+11%-0.002+6%-0.002+0%-0.003+22%
Usd Free Cash Flow---46783.000-105230.200+125%-128720.000+175%-96818.917+107%-94353.286+102%-94348.675+102%
Usd Free Cash Flow Per Share--0.000-0.001+125%-0.001+175%-0.001+107%-0.001+102%-0.001+102%
Usd Free Cash Flow To Equity Per Share--0.0000.000+106%0.000+103%0.000+190%0.000+685%0.000+115%
Usd Market Cap7229640.000-5%7624009.7525257937.760+45%6581185.430+16%4958892.550+54%4601947.430+66%5697961.426+34%
Usd Price Per Share0.055-5%0.0580.040+45%0.050+16%0.038+54%0.035+66%0.043+34%
Usd Profit---292798.000-349822.800+19%-324174.667+11%-303160.833+4%-290611.381-1%-355317.525+21%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share--0.0000.000-93%0.000-65%0.000-82%0.000-401%0.000-940%
 EOD+2 -6MRQTTM+20 -9YOY+15 -143Y+18 -115Y+19 -1110Y+20 -10

3.3 Fundamental Score

Let's check the fundamental score of Burzynski Research based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.173
Price to Book Ratio (EOD)Between0-1-173.636
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.020
Debt to Asset Ratio (MRQ)Less than150.158
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-345.688
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Burzynski Research based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.055
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Burzynski Research

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

Fundamental data was last updated by Penke on 2025-06-27 19:51:08.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Burzynski Research earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Burzynski Research:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--90.3%+90.3%
TTM--141.5%+141.5%
YOY--185.9%+185.9%
3Y--248.0%+248.0%
5Y--344.1%+344.1%
10Y--489.2%+489.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Burzynski Research is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • -34,568.8% Return on Assets means thatΒ Burzynski Research generatedΒ $-345.69 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Burzynski Research:

  • The MRQ is -34,568.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -31,962.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34,568.8%TTM-31,962.5%-2,606.3%
TTM-31,962.5%YOY-30,222.4%-1,740.1%
TTM-31,962.5%5Y-17,824.1%-14,138.4%
5Y-17,824.1%10Y-20,645.3%+2,821.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34,568.8%-11.5%-34,557.3%
TTM-31,962.5%-11.6%-31,950.9%
YOY-30,222.4%-11.4%-30,211.0%
3Y-24,412.2%-11.9%-24,400.3%
5Y-17,824.1%-12.2%-17,811.9%
10Y-20,645.3%-13.9%-20,631.4%
4.3.1.3. Return on Equity

Shows how efficient Burzynski Research is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Burzynski Research generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Burzynski Research:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-910.4%+910.4%
5Y-910.4%10Y-478.0%-432.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--15.0%+15.0%
YOY--14.4%+14.4%
3Y--17.0%+17.0%
5Y-910.4%-18.0%-892.4%
10Y-478.0%-20.4%-457.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Burzynski Research.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Burzynski Research is operatingΒ .

  • Measures how much profit Burzynski Research makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Burzynski Research:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.5%+229.5%
TTM--258.2%+258.2%
YOY--204.2%+204.2%
3Y--221.0%+221.0%
5Y--344.1%+344.1%
10Y--476.7%+476.7%
4.3.2.2. Operating Ratio

Measures how efficient Burzynski Research is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Burzynski Research:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.711-2.711
YOY-3.043-3.043
3Y-3.562-3.562
5Y-4.755-4.755
10Y-6.520-6.520
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Burzynski Research.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Burzynski Research is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.02Β means the company has $0.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Burzynski Research:

  • The MRQ is 0.020. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.032. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.020TTM0.032-0.013
TTM0.032YOY0.109-0.076
TTM0.0325Y0.353-0.320
5Y0.35310Y0.229+0.123
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0203.662-3.642
TTM0.0323.745-3.713
YOY0.1094.104-3.995
3Y0.0764.649-4.573
5Y0.3535.734-5.381
10Y0.2296.143-5.914
4.4.3.2. Quick Ratio

Measures if Burzynski Research is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Burzynski Research:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.018-0.018
TTM0.018YOY0.083-0.065
TTM0.0185Y0.278-0.260
5Y0.27810Y0.150+0.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.826-2.826
TTM0.0183.104-3.086
YOY0.0833.778-3.695
3Y0.0544.288-4.234
5Y0.2785.682-5.404
10Y0.1506.360-6.210
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Burzynski Research.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Burzynski ResearchΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Burzynski Research to Biotechnology industry mean.
  • A Debt to Asset Ratio of 50.16Β means that Burzynski Research assets areΒ financed with 5,015.8% credit (debt) and the remaining percentage (100% - 5,015.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Burzynski Research:

  • The MRQ is 50.158. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 55.485. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ50.158TTM55.485-5.327
TTM55.485YOY41.012+14.473
TTM55.4855Y33.594+21.891
5Y33.59410Y45.140-11.546
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ50.1580.324+49.834
TTM55.4850.349+55.136
YOY41.0120.329+40.683
3Y36.8070.339+36.468
5Y33.5940.349+33.245
10Y45.1400.384+44.756
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Burzynski Research is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Burzynski Research:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.149-0.149
5Y0.14910Y0.078+0.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.384-0.384
TTM-0.435-0.435
YOY-0.408-0.408
3Y-0.446-0.446
5Y0.1490.460-0.311
10Y0.0780.510-0.432
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Burzynski Research generates.

  • Above 15 is considered overpriced butΒ always compareΒ Burzynski Research to theΒ Biotechnology industry mean.
  • A PE ratio of -6.51 means the investor is paying $-6.51Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Burzynski Research:

  • The EOD is -6.173. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.510. Based on the earnings, the company is expensive. -2
  • The TTM is -3.861. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.173MRQ-6.510+0.337
MRQ-6.510TTM-3.861-2.648
TTM-3.861YOY-5.443+1.581
TTM-3.8615Y-4.110+0.248
5Y-4.11010Y-4.093-0.017
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.173-2.150-4.023
MRQ-6.510-2.004-4.506
TTM-3.861-2.524-1.337
YOY-5.443-3.716-1.727
3Y-4.095-3.703-0.392
5Y-4.110-6.057+1.947
10Y-4.093-6.653+2.560
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Burzynski Research:

  • The EOD is -38.634. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -40.741. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.529. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.634MRQ-40.741+2.107
MRQ-40.741TTM-17.529-23.213
TTM-17.529YOY-16.776-0.753
TTM-17.5295Y-14.308-3.221
5Y-14.30810Y-19.212+4.904
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-38.634-3.030-35.604
MRQ-40.741-2.710-38.031
TTM-17.529-3.643-13.886
YOY-16.776-4.385-12.391
3Y-16.191-5.050-11.141
5Y-14.308-8.550-5.758
10Y-19.212-9.339-9.873
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Burzynski Research is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -183.11 means the investor is paying $-183.11Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Burzynski Research:

  • The EOD is -173.636. Based on the equity, the company is expensive. -2
  • The MRQ is -183.107. Based on the equity, the company is expensive. -2
  • The TTM is -124.976. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-173.636MRQ-183.107+9.471
MRQ-183.107TTM-124.976-58.130
TTM-124.976YOY-560.113+435.137
TTM-124.9765Y14.983-139.960
5Y14.98310Y-29.630+44.613
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-173.6361.883-175.519
MRQ-183.1071.855-184.962
TTM-124.9762.119-127.095
YOY-560.1132.469-562.582
3Y-256.1512.504-258.655
5Y14.9833.657+11.326
10Y-29.6304.297-33.927
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-02-28. Currency in USD. All numbers in thousands.

Summary
Total Assets1
Total Liabilities42
Total Stockholder Equity-42
 As reported
Total Liabilities 42
Total Stockholder Equity+ -42
Total Assets = 1

Assets

Total Assets1
Total Current Assets1
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1
Total Current Assets  (as reported)1
Total Current Assets  (calculated)1
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities42
Long-term Liabilities0
Total Stockholder Equity-42
Total Current Liabilities
Accounts payable 17
Total Current Liabilities  (as reported)42
Total Current Liabilities  (calculated)17
+/- 25
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-42
Total Stockholder Equity (calculated)0
+/- 42
Other
Capital Stock131
Common Stock Shares Outstanding 131,448
Net Invested Capital -42
Net Working Capital -42



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-02-282024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-02-291999-11-301999-08-311999-05-31
> Total Assets 
0
0
0
195
114
108
98
78
92
69
69
87
66
86
82
65
74
69
77
78
66
61
57
95
21
20
19
19
13
31
13
9
10
11
19
15
16
21
19
20
23
25
21
21
22
20
26
20
21
18
17
6
4
4
3
2
2
4
8
4
4
2
2
1
4
1
1
1
11
0
1
36
29
17
45
34
22
13
46
33
20
9
3
2
1
2
2
7
5
5
2
2
2
1
2
1
2
1
2
1
1
112121212225572212392033461322344517293610111114122448422344617182120262022212125232019211615191110913311319192021955761667877697465828666876969927898108114195000
   > Total Current Assets 
0
0
0
20
7
12
13
4
23
4
8
19
2
26
23
11
20
16
25
27
17
14
11
91
18
17
16
17
11
22
5
1
3
4
12
9
11
16
13
15
18
20
16
17
17
16
22
16
17
15
14
3
1
1
1
0
0
2
6
2
2
0
1
1
3
1
0
1
11
0
1
36
29
17
45
34
22
13
46
33
20
9
3
2
1
2
2
7
5
5
2
2
2
1
2
1
2
1
2
1
1
112121212225572212392033461322344517293610111013110226200111314151716221617171620181513161191243152211171617189111141727251620112326219842341312720000
       Cash And Cash Equivalents 
0
0
0
20
7
12
13
4
23
4
8
19
2
25
23
11
19
16
25
27
17
14
11
11
18
17
16
17
11
22
5
1
3
4
12
9
11
16
13
15
18
20
16
17
17
16
22
16
17
15
14
3
1
1
1
0
0
2
6
2
2
0
1
1
3
1
0
1
1
0
1
3
1
0
0
0
1
3
1
0
0
0
2
1
0
1
1
6
3
5
1
2
1
0
1
1
1
0
1
1
1
1110111012153611012000131000131011013110226200111314151716221617171620181513161191243152211171617181111141727251619112325219842341312720000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000008000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
0
33
28
17
45
33
21
10
45
32
20
9
1
1
1
1
1
1
1
1
0
0
1
1
0
0
1
1
0
0
0
00011001100111111119203245102133451728330101000000000000000000000000000000000000000000000000000010010000000000000
   > Long-term Assets 
0
0
0
174
106
96
84
75
69
65
60
68
64
60
59
54
54
53
52
50
49
48
46
4
4
3
3
3
2
9
8
8
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000001111112222223333334444445555666677889233344464849505253545459606468606569758496106174000
       Property Plant Equipment 
0
0
0
170
106
96
84
75
69
65
60
68
64
60
59
54
54
53
52
50
49
48
46
4
4
3
3
3
2
9
8
8
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000001111112222223333334444445555666677889233344464849505253545459606468606569758496106170000
> Total Liabilities 
0
0
0
209
85
112
43
28
58
74
54
87
70
109
84
110
107
92
132
103
87
86
65
50
50
72
58
41
66
96
89
86
69
81
88
57
104
129
203
113
71
87
127
49
73
92
37
48
62
136
46
90
89
137
179
195
153
134
137
115
142
132
135
128
105
63
110
73
44
89
129
163
137
153
213
206
209
213
229
216
172
255
204
131
47
63
30
1
3
44
15
28
16
71
6
36
27
129
89
22
42
422289129273667116281544313063471312042551722162292132092062131531371631298944731106310512813513214211513713415319517913789904613662483792734912787711132031291045788816986899666415872505065868710313292107110841097087547458284311285209000
   > Total Current Liabilities 
0
0
0
209
85
112
43
28
58
74
54
87
70
109
84
110
107
92
132
103
87
86
65
50
50
72
58
41
66
96
89
86
69
81
88
57
104
129
203
113
71
87
127
49
73
92
37
48
62
136
46
90
89
137
179
195
153
134
137
115
142
132
135
128
105
63
110
73
44
89
129
163
137
153
213
206
209
213
229
216
172
255
204
131
47
63
30
1
3
44
15
28
16
71
6
36
27
129
89
22
42
422289129273667116281544313063471312042551722162292132092062131531371631298944731106310512813513214211513713415319517913789904613662483792734912787711132031291045788816986899666415872505065868710313292107110841097087547458284311285209000
       Short-term Debt 
0
0
0
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000015000
       Accounts payable 
0
0
0
48
27
57
12
1
11
46
21
32
23
46
25
66
56
45
86
59
47
45
28
14
14
37
23
19
44
48
47
49
33
53
74
40
78
103
178
88
42
22
97
19
39
26
3
4
12
55
11
53
48
40
153
163
114
108
113
91
100
82
93
87
64
46
79
49
20
60
61
68
42
65
96
98
101
97
93
94
61
142
86
22
33
30
19
1
0
14
2
17
13
23
0
20
9
71
77
18
17
171877719200231317214011930332286142619493971019896654268616020497946648793821009111310811416315340485311551243263919972242881781037840745333494748441923371414284547598645566625462332214611112572748000
       Other Current Liabilities 
0
0
0
155
57
54
30
26
46
28
32
55
47
63
59
44
51
47
47
43
39
41
37
36
36
35
35
21
22
48
42
37
35
28
14
17
25
26
25
26
30
65
30
30
34
66
33
44
50
81
35
37
41
97
26
32
39
26
24
24
42
51
42
40
41
17
31
24
24
29
68
95
95
88
117
107
108
116
136
122
112
113
118
110
14
33
10
0
3
30
13
12
3
49
6
16
18
58
12
4
0
041258181664931213303010331411011811311212213611610810711788959568292424311741404251422424263932269741373581504433663430306530262526251714283537424822213535363637413943474751445963475532284626305457155000
   > Long-term Liabilities 
0
0
0
0
28
57
12
1
11
46
21
32
23
46
25
66
0
45
86
59
47
45
28
14
14
37
23
19
44
48
47
49
33
53
74
40
78
103
178
88
0
22
97
19
39
26
3
4
12
55
11
53
48
40
153
163
114
108
113
91
100
82
93
87
0
46
79
49
20
60
61
68
42
65
96
98
101
97
93
94
61
142
86
22
33
30
19
1
0
14
2
17
13
0
0
0
0
0
0
0
0
00000000131721401193033228614261949397101989665426861602049794608793821009111310811416315340485311551243263919972208817810378407453334947484419233714142845475986450662546233221461111257280000
> Total Stockholder Equity
0
0
0
-14
29
-3
55
51
34
-5
15
0
-5
-23
-2
-45
-33
-24
-56
-25
-21
-24
-8
45
-28
-52
-39
-21
-53
-65
-76
-77
-58
-70
-70
-43
-87
-108
-184
-93
-48
-62
-106
-27
-51
-72
-10
-28
-41
-118
-28
-85
-85
-133
-176
-193
-151
-130
-130
-111
-138
-131
-133
-126
-101
-62
-109
-72
-33
-89
-128
-127
-108
-137
-167
-172
-187
-200
-182
-183
-153
-245
-201
-129
-46
-61
-28
5
1
-39
-14
-27
-14
-71
-4
-35
-25
-128
-88
-21
-42
-42-21-88-128-25-35-4-71-14-27-14-3915-28-61-46-129-201-245-153-183-182-200-187-172-167-137-108-127-128-89-33-72-109-62-101-126-133-131-138-111-130-130-151-193-176-133-85-85-28-118-41-28-10-72-51-27-106-62-48-93-184-108-87-43-70-70-58-77-76-65-53-21-39-52-2845-8-24-21-25-56-24-33-45-2-23-5015-5345155-329-14000
   Common Stock
0
0
0
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
131
0
0131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131131000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000-22-220-22-22-22-21-21-210-210-200-20-20-20-20-19-19-19-19-19-18-18-18-18-18-18-17-17-17-17000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
42,344
46,980
48,363
49,739
50,954
52,161
53,199
54,235
55,328
56,543
57,589
58,751
59,596
60,899
62,201
63,381
64,573
65,876
67,056
68,380
69,472
70,470
71,603
72,763
73,739
74,747
75,796
76,939
77,967
79,264
80,535
820,062
83,195
84,363
85,462
86,580
87,879
89,250
90,594
91,755
93,043
94,261
95,741
97,588
99,410
101,428
103,032
104,916
106,389
107,884
109,192
110,256
111,222
112,090
112,951
113,678
114,404
114,994
115,626
116,134
116,601
117,058
117,445
117,800
118,221
118,609
119,014
119,401
119,803
120,146
120,527
120,946
121,381
121,705
122,160
122,588
123,059
123,374
123,739
124,112
124,448
124,685
124,985
125,244
125,542
125,708
125,900
126,141
126,381
126,610
126,840
127,158
127,561
127,934
128,202
128,612
129,031
0
0129,031128,612128,202127,934127,561127,158126,840126,610126,381126,141125,900125,708125,542125,244124,985124,685124,448124,112123,739123,374123,059122,588122,160121,705121,381120,946120,527120,146119,803119,401119,014118,609118,221117,800117,445117,058116,601116,134115,626114,994114,404113,678112,951112,090111,222110,256109,192107,884106,389104,916103,032101,42899,41097,58895,74194,26193,04391,75590,59489,25087,87986,58085,46284,36383,195820,06280,53579,26477,96776,93975,79674,74773,73972,76371,60370,47069,47268,38067,05665,87664,57363,38162,20160,89959,59658,75157,58956,54355,32854,23553,19952,16150,95449,73948,36346,98042,344000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-02-28. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-1,386
Operating Income-1,386-1,386
 
Operating Expense (+$)
Research Development1,046
Selling General Administrative340
Selling And Marketing Expenses0
Operating Expense1,3861,386
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-1,386
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,386-1,386
EBIT - interestExpense = 0
-1,386
-1,386
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-1,386
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,386
Tax Provision-0
Net Income From Continuing Ops-1,386-1,386
Net Income-1,386
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Burzynski Research
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Burzynski Research. The general trend of Burzynski Research is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Burzynski Research's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Burzynski Research Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Burzynski Research.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.055 < 0.055 < 0.055.

The bearish price targets are: 0.032 > 0.032 > 0.031.

Know someone who trades $BZYR? Share this with them.πŸ‘‡

Burzynski Research Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Burzynski Research. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Burzynski Research Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Burzynski Research.

Burzynski Research Daily Moving Average Convergence/Divergence (MACD) ChartBurzynski Research Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Burzynski Research. The current adx is .

Burzynski Research Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Burzynski Research.

Burzynski Research Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Burzynski Research.

Burzynski Research Daily Relative Strength Index (RSI) ChartBurzynski Research Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Burzynski Research.

Burzynski Research Daily Stochastic Oscillator ChartBurzynski Research Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Burzynski Research.

Burzynski Research Daily Commodity Channel Index (CCI) ChartBurzynski Research Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Burzynski Research.

Burzynski Research Daily Chande Momentum Oscillator (CMO) ChartBurzynski Research Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Burzynski Research.

Burzynski Research Daily Williams %R ChartBurzynski Research Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Burzynski Research.

Burzynski Research Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Burzynski Research.

Burzynski Research Daily Average True Range (ATR) ChartBurzynski Research Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Burzynski Research.

Burzynski Research Daily On-Balance Volume (OBV) ChartBurzynski Research Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Burzynski Research.

Burzynski Research Daily Money Flow Index (MFI) ChartBurzynski Research Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Burzynski Research.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Burzynski Research Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Burzynski Research based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.055
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Burzynski Research with someone you think should read this too:
  • Are you bullish or bearish on Burzynski Research? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Burzynski Research? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Burzynski Research

I send you an email if I find something interesting about Burzynski Research.


Comments

How you think about this?

Leave a comment

Stay informed about Burzynski Research.

Receive notifications about Burzynski Research in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.